BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
3.310
-0.110 (-3.22%)
At close: Oct 9, 2026, 4:00 PM EDT
3.350
+0.040 (1.21%)
After-hours: Oct 9, 2026, 7:30 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $265.38 million as of October 9, 2026. It is the 19,232nd most valuable company in the world and the 3,360th biggest in the United States. Its market cap has decreased by 72.13% in one year.
Market Cap
265.38M
Enterprise Value
-76.24M
1-Year Change
-72.13%
Global Rank
Country Rank
#3,360 United States
Category
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $265.38M, an increase of 594.48%. That is a compound annual growth rate of 106.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 265.38M | -73.50% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 276.31M |
| Bicycle Therapeutics | 272.27M |
| SAB Biotherapeutics | 271.14M |
| Palisade Bio | 268.38M |
| Century Therapeutics | 266.18M |
| Lexeo Therapeutics | 265.00M |
| Fate Therapeutics | 261.21M |
| Vogenx | 260.86M |